The FDA is expanding the approved use of Abbott's (ABT -1%) Humira to include treatment of...

|About: Abbott Laboratories (ABT)|By:, SA News Editor

The FDA is expanding the approved use of Abbott's (ABT -1%) Humira to include treatment of moderate-to-severe ulcerative colitis in adults, when immunosuppressant medicines have not worked. The drug is currently approved for use in reducing the signs and symptoms of rheumatoid arthritis.